To conclude, consistent with published functional studies linking tapasin to efficient antigen presentation and tumor immune recognition by CD8+ CTLs, reduced expression of tapasin is associated with tumor progression in CRC. This evidence concerns the gene TAPBP and colorectal carcinoma.